Stocks and Investing Stocks and Investing
Tue, May 30, 2023
Mon, May 29, 2023
Sun, May 28, 2023
Fri, May 26, 2023

Yigal Nochomovitz Maintained (UBX) at Strong Buy with Increased Target to $6 on, May 26th, 2023


Published on 2024-10-28 04:03:58 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Increased Target from $5 to $6 on, May 26th, 2023.

Yigal has made no other calls on UBX in the last 4 months.



There are 4 other peers that have a rating on UBX. Out of the 4 peers that are also analyzing UBX, 0 agree with Yigal's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Yigal


  • Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Wednesday, May 10th, 2023
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Decreased Target to $3 on, Tuesday, April 25th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, March 28th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023
Contributing Sources